Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Other Opioid Crisis

April 1, 2016 8:38 am | by Luke Messac, University of Pennsylvania, The Conversation | News | Comments

There are two opioid crises in the world today. Read more...

TOPICS:

Tick Saliva Could Help Make New Blood Disorder Treatment

April 1, 2016 8:31 am | by Monash University | News | Comments

Scientists found a connection between tick saliva proteins and eculizumab. Read more...

TOPICS:

Cancer Drug Could Treat Blood Vessel Deformities

April 1, 2016 8:31 am | by University College London | News | Comments

VMs are characterized by deformed, swollen blood vessels. Read more...

TOPICS:
Advertisement

FDA Grants Approval for Roche to Test Blood Samples for Zika

April 1, 2016 8:30 am | News | Comments

Initially, the cobas Zika test will be deployed to screen blood donations collected locally in Puerto Rico. Read more...

TOPICS:

New Method Measures Type 2 Diabetes Risk in Blood

April 1, 2016 8:30 am | by Lund University | News | Comments

The predictive potential of the current method is modest, but new methods are needed. Read more...

TOPICS:

Pharmacy on Demand

April 1, 2016 8:29 am | by Anne Trafton, MIT News Office | News | Comments

New, portable system can be configured to produce different drugs. Read more...

TOPICS:

GSK to Reduce Drug Patents in Poor Countries

March 31, 2016 1:16 pm | by Stephanie Guzowski, Editor | News | Comments

In an attempt to broaden global access to expensive medications, GlaxoSmithKline (GSK) announced Thursday it will adopt a graduated approach to patenting its drugs, depending on the wealth of countries. Read more..

TOPICS:

Genfit Plans to Test Its Drug in Second Liver Disease

March 31, 2016 12:13 pm | by Bill Berkrot, Reuters | News | Comments

French drugmaker Genfit SA on Thursday said it would begin a midstage trial this year of its experimental drug elafibranor to treat primary biliary cholangitis, a chronic disease in which bile ducts in the liver are gradually destroyed. Read more...

TOPICS:
Advertisement

Brilinta Preferred Over Clopidogrel in Updated Acute Coronary Syndrome Guidelines

March 31, 2016 10:52 am | News | Comments

First major US guideline to include expanded indication for Brilinta in patients with a heart attack beyond one year. Read more...

TOPICS:

Janssen's Phase 3 Trial of Daratumumab in Multiple Myeloma Meets Primary Endpoint

March 31, 2016 10:45 am | News | Comments

Janssen announced today positive results of a pre-planned interim analysis of the Phase 3 MMY3004 (CASTOR) trial evaluating the efficacy and safety of daratumumab, a CD38-directed monoclonal antibody (mAb), in combination with bortezomib and dexamethasone, compared to bortezomib and dexamethasone alone, in patients with relapsed or refractory multiple myeloma. Read more...

TOPICS:

Phase-3 Drug Trial for Refractory RA Succeeds, Stanford Scientist Says

March 31, 2016 10:34 am | by Stanford Unversity | News | Comments

In a pivotal phase-3 trial led by a Stanford University School of Medicine investigator, a novel drug for rheumatoid arthritis substantially reduced symptoms and improved daily physical functioning in patients for whom other therapies had failed. Read more..

TOPICS:

JAMA Cardiology: Phase 2 Results of AC6 Gene Transfer in Patients with HF

March 31, 2016 10:27 am | News | Comments

Renova Therapeutics, a biopharmaceutical company developing gene therapy treatments for cardiovascular and metabolic diseases, announced the publication of Phase 2 clinical trial results of AC6 gene transfer for the treatment of patients with heart failure and reduced ejection fraction in JAMA Cardiology. Read more..

TOPICS:

Valeant Tries to Delay Release of Financial Statements

March 31, 2016 8:53 am | by The Associated Press | News | Comments

The company needs an extension because if the annual report is not filed by April 29. Read more...

TOPICS:

Embattled Stem Cell Scientist Says Charges Against Him Are False

March 31, 2016 8:50 am | by Maria Cheng, AP Medical Writer | News | Comments

Macchiarini's research was once thought to be revolutionary in the field of regenerative medicine. Read more...

TOPICS:

Study Confirms Link Between Diabetes Drug, Higher Bladder Cancer Risk

March 31, 2016 8:47 am | by British Medical Journal | News | Comments

The diabetes drug pioglitazone is associated with an increased risk of bladder cancer. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading